American Journal of Epidemiology Vol. 135, No. 10: 1083-1092
Copyright © 1992 by The Johns Hopkins University School of Hygiene and Public Health
other |
Vitamin Supplement Use and Reduced Risk of Oral and Pharyngeal Cancer
1National Cancer Institute, Division of Cancer Etiology, Epidemiology and Biostatistics Program Bethesda, MD
2National Cancer Institute, Division of Cancer Prevention and Control Bethesda, MD
Reprint requests to Ms. Gloria Gridley, National Cancer Institute, Executive Plaza North, Room 443, Bethesda, MD 20892
Use of vitamin and mineral supplements was assessed in a population-based case-control study of oral and pharyngeal cancer, conducted during 1984–1985 in four areas of the United States. There was no association with intake of multivitamin products, but users of supplements of individual vitamins, including vitamins A, B, C, and E, were at lower risk after controlling for the effects of tobacco, alcohol, and other risk factors for these cancers. After further adjustment for use of other supplements, vitamin E was the only supplement that remained associated with a significantly reduced cancer risk. The adjusted odds ratio of oral and pharyngeal cancer for "ever regularly used" vitamin E was 0.5 (95% confidence interval 0.4–0.6). To the authors' knowledge, this is the first epidemiologic study to show a reduced oral cancer risk with vitamin E use. Although it is not clear that the lower risk among consumers of vitamin E supplements is due to the vitamin per se, the findings are consistent with experimental evidence and should prompt further research on the role of vitamin E and other micronutrients as inhibitors of oral and pharyngeal cancer. Am J Epidemiol 1992; 135: 1083–92
mouth neoplasms; neoplasms; pharyngeal neoplasms; retrospective studies; risk factors; vitamin E; vitamins
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  I. Bairati, F. Meyer, M. Gelinas, A. Fortin, A. Nabid, F. Brochet, J.-P. Mercier, B. Tetu, F. Harel, B. Masse, et al. A Randomized Trial of Antioxidant Vitamins to Prevent Second Primary Cancers in Head and Neck Cancer Patients J Natl Cancer Inst, April 6, 2005; 97(7): 481 - 488. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 The HOPE and HOPE-TOO Trial Investigators Effects of Long-term Vitamin E Supplementation on Cardiovascular Events and Cancer: A Randomized Controlled Trial JAMA, March 16, 2005; 293(11): 1338 - 1347. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. Conney Enzyme Induction and Dietary Chemicals as Approaches to Cancer Chemoprevention: The Seventh DeWitt S. Goodman Lecture Cancer Res., November 1, 2003; 63(21): 7005 - 7031. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. C. Willett Diet and Cancer Oncologist, October 1, 2000; 5(5): 393 - 404. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. L. Schwartz Biomarkers and Molecular Epidemiology and Chemoprevention of Oral Carcinogenesis Critical Reviews in Oral Biology & Medicine, January 1, 2000; 11(1): 92 - 122. [Abstract] [Full Text] [PDF]
|
|